Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Intellia Therapeutics (NTLA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Intellia Therapeutics (NTLA) over the last 10 years, with Q3 2025 value amounting to 0.06.

  • Intellia Therapeutics' Asset Utilization Ratio rose 7309.66% to 0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06, marking a year-over-year increase of 7309.66%. This contributed to the annual value of 0.05 for FY2024, which is 8062.13% up from last year.
  • Latest data reveals that Intellia Therapeutics reported Asset Utilization Ratio of 0.06 as of Q3 2025, which was up 7309.66% from 0.06 recorded in Q2 2025.
  • Over the past 5 years, Intellia Therapeutics' Asset Utilization Ratio peaked at 0.07 during Q1 2021, and registered a low of 0.02 during Q3 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.04, with a median of 0.04 in 2022.
  • In the last 5 years, Intellia Therapeutics' Asset Utilization Ratio tumbled by 8271.24% in 2021 and then surged by 13633.37% in 2022.
  • Quarter analysis of 5 years shows Intellia Therapeutics' Asset Utilization Ratio stood at 0.02 in 2021, then skyrocketed by 101.23% to 0.04 in 2022, then fell by 28.75% to 0.03 in 2023, then skyrocketed by 71.69% to 0.05 in 2024, then grew by 28.83% to 0.06 in 2025.
  • Its last three reported values are 0.06 in Q3 2025, 0.06 for Q2 2025, and 0.04 during Q1 2025.